-
Pharmac To Fund Five Medicines For Multiple Sclerosis, Breast Cancer, Eye Conditions, And Lung Cancer
12 Nov 2025 01:12 GMT
… , breast cancer, eye conditions, and lung cancer will benefit from five medicines … ROS1-positive non-small cell lung cancer.
Bevacizumab (Avastin) – secured ongoing access to … funding for faricimab (Vabysmo) and lung cancer treatments. It will use this …
-
<![CDATA[Efforts to Leverage NaPi2b Are Renewed With Novel ADC in Ovarian Cancer]]>
13 Nov 2025 20:23 GMT
… , and nonsquamous non–small cell lung cancers (NSCLC), underscoring its relevance across … carboplatin with or without bevacizumab (Avastin) in patients with platinum-sensitive … for the data from the lung cancer cohort, [which will tell us …
-
<![CDATA[ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors]]>
13 Oct 2025 22:18 GMT
… trials exploring HER2 alterations in lung tumors, here are some of the … advanced squamous non–small cell lung cancer (NSCLC).
Previously, developers announced prespecified … “overcome the limitations of bevacizumab [Avastin] in treating squamous [NSCLC]” while …
-
Private cancer patients to get access to Pharmac-funded medicine
12 Nov 2025 05:37 GMT
… -small cell lung cancer
And fund ongoing access to:
Bevacizumab (Avastin) for people …
-
First cancer medicine available in private hospitals
12 Nov 2025 03:33 GMT
… treatments, including for breast and lung cancer, from 1 December 2025.
Pharmac … ROS1-positive non-small cell lung cancer
Bevacizumab (Avastin) for people with eye …
-
Finishing Chemo with Stage 4 Lung Cancer: Facing Hope and Uncertainty
07 Aug 2025 01:09 GMT
… a stage 4 diagnosis of lung cancer.
After her diagnosis, she spent … (Keytruda [pembrolizumab]), two rounds of Avastin (bevacizumab), and one additional round …
-
StockWatch: Recursion Slides on Data Update as New CEO Named
09 Nov 2025 21:15 GMT
… )
Pancreatic cancer
Non-small cell lung cancer (NSCLC)
Breast cancer (hormone receptor … studied are REC-617 plus Avastin® (bevacizumab) marketed by Roche and …
-
Combining Avastin With Alecensa Shows Promise in Advanced ALK-Positive Lung Cancer
29 May 2025 23:14 GMT
… clinical trial found that adding Avastin (bevacizumab) to Alecensa (alectinib … lymphoma kinase (ALK)-positive lung cancer, which then delayed disease … 9% of non–small cell lung cancer (NSCLC) cases, the … (stage IV) non-squamous lung cancer, and about 17% had …
-
Biosimilar Mvasi Demonstrates Similar Ophthalmic Safety Profile to Reference Product Avastin
31 Jul 2025 19:25 GMT
… biosimilar of reference bevacizumab (Avastin; Genentech), demonstrated a … cancer, non–small cell lung cancer, glioblastoma, metastatic cervical … high similarity to Avastin without clinically meaningful … “Given that both Avastin and Mvasi require compounding …
-
Analysis of the Effects of Bevacizumab Combined with Chemoradiotherapy on VEGF, bFGF, and Let-7 Levels in Non-Small Cell Lung Cancer and the Factors Influencing Therapeutic Efficacy: A Retrospective Cohort Study
02 Dec 2024 18:59 GMT
… subtypes, non-small cell lung cancer (NSCLC) predominates, accounting … of lung cancer and induce cell cycle arrest of lung cancer … JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, … AB, et al. Bevacizumab (Avastin®) in cancer treatment: a …
About
© 1995-2025